story of the week
Concomitant Administration of EGFRvIII-Targeted CAR T-Cell Therapy and Pembrolizumab in Adults With Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Nat Cancer 2024 Jan 12;[EPub Ahead of Print], SJ Bagley, ZA Binder, L Lamrani, E Marinari, AS Desai, MP Nasrallah, E Maloney, S Brem, RA Lustig, G Kurtz, M Alonso-Basanta, PE Bonté, C Goudot, W Richer, E Piaggio, S Kothari, L Guyonnet, CL Guerin, JJ Waterfall, S Mohan, WT Hwang, OY Tang, M Logun, M Bhattacharyya, K Markowitz, D Delman, A Marshall, EJ Wherry, S Amigorena, GL Beatty, JL Brogdon, E Hexner, D Migliorini, C Alanio, DM O'RourkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.